Overview +

Vaginal Cancer Human Serum for Research

Our Vaginal Cancer Serum is sourced from IRB-consented donors clinically diagnosed with vaginal cancer. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for biomarker studies.

Product Features

  • Collected from clinically confirmed donors
  • Research Use Only (RUO)
  • IRB-approved protocols with documented consent

Donor Metadata

  • Oncology diagnosis confirmation
  • Age, sex assigned at birth, and ethnicity
  • Donor-reported allergy and infectious disease history

Applications

  • Biomarker discovery for vaginal cancer
  • Metabolic and protein profiling
  • Therapeutic candidate screening and validation

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Vaginal cancer serum is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.

Protocols and Documentation +

Document Type Technical Document
PDF > Serum Isolation

Publications +

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.